Ipath.B S&P 500 VIX Short-Term Futures ETN (VXX)
$21.16 0.13 (0.61%)
11:31 EDT VXX Stock Quote Delayed 15 Minutes
Previous Close $21.29
Market Cap 662.68M
PE Ratio -
Volume (Avg. Vol.) 11.98M
Day's Range 21.07 - 21.46
52-Week Range 20.97 - 51.99
Dividend & Yield N/A (N/A)
VXX Stock Predictions, Articles, and Ipath.B S&P 500 VIX Short-Term Futures ETN News
- From InvestorPlace
- From the Web
The GLD, TLT and VXX are 3 stock to trade into the Fed event. Wall Street is still too comfortable with them -- so there is more downside.
As tariff worries come to a head between the U.S. and China, these corners of the market are more likely to keep investors' money safe.
Stocks suffered their worst one-day decline on Thursday since the panic of Feb. 8. With that in mind, investors should expect more volatility in the hours ahead.
Stocks slumped hard on Thursday reversing early session gains after President Trump surprised the world by announcing tariffs on imported steel and aluminum of 25% and 10%, respectively.
Stocks rolled over and dropped hard on Wednesday, reversing an opening gap higher and a mid-day recovery attempt to careen deep into the red in a nasty end-of-session slide.
Stocks succumbed to a nasty bought of selling pressure on Tuesday after new Federal Reserve chairman Jerome Powell sounded a hawkish note in his first appearance to Congress.
Stocks rebounded strongly on Wednesday in the wake of what looked, on the surface, to be a strong Consumer Price Inflation report.
Investments in the stock market have a positive expectation over time. Volatility products and volatility ETFs are literally gambling, and in some cases you're just handing your money over to the casino.
The Dow Jones lost 4.6% and suffered its largest-ever point decline at 1,175 on Monday -- with the losses continuing to deepen in the overnight futures session.
These inverse ETFs could prove beneficial if markets turn rocky.
Concerns continue to grow over Trump's ability to implement his corporate agenda as the Dow Jones and small-cap stocks deflate.
Keep an eye on these ETFs as the Dow rolls over amid hawkish Fed minutes and an increasingly volatile response from Trump on Charlottesville.
U.S. equities finished sharply lower on Thursday as the bond market displayed weakness, pushing long-term interest rates higher.
Some ETFs are great and can work wonders in your portfolio. But the ones in this list are ETFs to sell, and now, because they're unlikely to be helping.
I think there’s more volatility in this market than they’re saying at this point. I expect the VIX to rise again, which would be advantageous to this position.
The iPath S&P 500 VIX Short-Term Futures TM ETN (VXX) offers exposure to the volatility of the "fear index". Is VXX right for you?
Investors in Ipath Series B Standard and Poors 500 Vix Short-term Futures Etn (VXX) saw new options begin trading today, for the November 29th expiration. At Stock Options Channel, our YieldBoost formula has looked up and down the VXX options chain for the new November 29th contracts and identified one put and one call contract of particular interest.
Investors in Ipath Series B Standard and Poors 500 Vix Short-term Futures Etn (VXX) saw new options begin trading this week, for the January 2022 expiration. One of the key inputs that goes into the price an option buyer is willing to pay, is the time value, so with 857 days until expiration the newly trading contracts represent a potential opportunity for sellers of puts or calls to achieve a higher premium than would be available for the contracts with a closer expiration..
Investors in Ipath Series B Standard and Poors 500 Vix Short-term Futures Etn (VXX) saw new options become available today, for the November 1st expiration. At Stock Options Channel, our YieldBoost formula has looked up and down the VXX options chain for the new November 1st contracts and identified one put and one call contract of particular interest.
10 Stocks Set for Monster Growth
He found Apple at $4… Oracle at $6… Amazon at $40… Now legendary growth investor Louis Navellier is giving away his latest Research Report — for FREE!
Download your FREE COPY!